Diagnostic biomarkers and immune infiltration profiles common to COVID-19, acute myocardial infarction and acute ischaemic stroke using bioinformatics methods and machine learning.

Journal: BMC neurology
PMID:

Abstract

BACKGROUND: COVID-19 is a disease that affects people globally. Beyond affecting the respiratory system, COVID-19 patients are at an elevated risk for both venous and arterial thrombosis. This heightened risk contributes to an increased probability of acute complications, including acute myocardial infarction (AMI) and acute ischemic stroke (AIS). Given the unclear relationship between COVID-19, AMI, and AIS, it is crucial to gain a deeper understanding of their associations and potential molecular mechanisms. This study aims to utilize bioinformatics to analyze gene expression data, identify potential therapeutic targets and biomarkers, and explore the role of immune cells in the disease.

Authors

  • Ya-Nan Ma
    Department of Geriatrics and Specialty Medicine, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China.
  • Si-Rong Ma
    School of Basic Medical Sciences, Ningxia Medical University, Yinchuan, Ningxia, China.
  • Li Yang
    Department of Pharmacy, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  • Juan Wu
  • Ya-Rong Wang
    Department of Geriatrics and Specialty Medicine, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China.
  • Li-Jia Bao
    Department of Geriatrics and Specialty Medicine, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China.
  • Li Ma
    Department of Technological Research and Development, Hunan Guanmu Biotech Co., Ltd, Changsha, China.
  • Qing-Qiu Wu
    Department of Geriatrics and Specialty Medicine, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China. wqq9455@163.com.
  • Zhen-Hai Wang
    Institute of Medical Sciences, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China. nyfywzh@163.com.